Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 3, 2015 - Issue 6
Submit an article Journal homepage
59
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pixantrone dimaleate for treating non-Hodgkin’s lymphoma

Ruth PettengellSt. Georges Hospital, Medical Oncology, Blackshaw Road, London, SW170QT, [email protected]
&
Jasvinder KaurSt. Georges Hospital, Medical Oncology, Blackshaw Road, London, SW170QT, [email protected]
Pages 747-757 | Published online: 18 May 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Barbara Jezeršek Novaković, Lučka Boltežar & Aleksander Novaković. (2021) Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma. Therapeutics and Clinical Risk Management 17, pages 183-192.
Read now
Giorgio Minotti, Haiyong Han, Valérie Cattan, Anton Egorov & Francesco Bertoni. (2018) Pixantrone: novel mode of action and clinical readouts. Expert Review of Hematology 11:7, pages 587-596.
Read now

Articles from other publishers (10)

Manmeet Kaur, Mandeep Kaur, Tania Bandopadhyay, Aditi Sharma, Anu Priya, Arvind Singh & Bubun Banerjee. (2023) Naturally occurring, natural product inspired and synthetic heterocyclic anti-cancer drugs. Physical Sciences Reviews 8:10, pages 3393-3446.
Crossref
Cristina Barrenetxea Lekue, Silvina Grasso Cicala, Sirpa Leppä, Thomas Stauffer Larsen, Susana Herráez Rodríguez, Clara Alonso Caballero, Judit M. Jørgensen, Helle Toldbod, Irene Leal Martínez & Francesco D’Amore. (2019) Pixantrone beyond monotherapy: a review. Annals of Hematology 98:9, pages 2025-2033.
Crossref
Patrick Therasse, Beatrice Perron, Sarah A Novack & Jean-Pierre Abastado. (2017) The Servier oncology pipeline in 2017. Future Oncology 13:17, pages 1527-1536.
Crossref
Gillian M. Keating & Katherine A. Lyseng-Williamson. (2017) Pixantrone in relapsed or refractory aggressive non-Hodgkin’s lymphoma: a guide to its use. Drugs & Therapy Perspectives 33:4, pages 160-166.
Crossref
Francesco Malaspina, Cinzia Pellegrini, Beatrice Casadei, Lisa Argnani & Pier Luigi Zinzani. (2017) Impressive Response to Pixantrone after Allogeneic Transplant in a Multiple Relapsed Diffuse Large B-Cell Lymphoma. Acta Haematologica 137:4, pages 191-194.
Crossref
Longcheng Hong, Sebastian Ahles, Marcel A. Strauss, Christian Logemann & Hermann A. Wegner. (2017) Synthesis of 2,3-diaza-anthraquinones via the bidentate Lewis acid catalysed inverse electron-demand Diels–Alder (IEDDA) reaction. Organic Chemistry Frontiers 4:5, pages 871-875.
Crossref
Pier Luigi Zinzani, Paolo Corradini, Maurizio Martelli, Giorgio Minotti, Stefano Oliva, Michele Spina, Giovanni Barosi & Sante Tura. (2016) Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper. European Journal of Haematology 97:6, pages 554-561.
Crossref
Gillian M. Keating. (2016) Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma. Drugs 76:16, pages 1579-1586.
Crossref
Christian Gisselbrecht & Eric Van Den Neste. (2016) Bridging to Transplant in Diffuse Large B Cell Lymphoma. EMJ Hematology, pages 91-99.
Crossref
B. B. Hasinoff, X. Wu, D. Patel, R. Kanagasabai, S. Karmahapatra & J. C. Yalowich. (2015) Mechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase II  Isoform. Journal of Pharmacology and Experimental Therapeutics 356:2, pages 397-409.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.